John Matthews brings 30 years of success within the pharmaceutical and CRO sector, with deep expertise across a wide range of therapeutic areas. He has a proven track record in delivering large, global clinical trials that are inspection ready, consistently meeting the highest standards of quality and regulatory compliance. As a former Vice President at Syneos Health, John was responsible for leading a key partnership with a major pharmaceutical client, successfully delivering $1 billion in revenues. He holds a Master’s degree in Forensic Science from King’s College London, further underpinning his strong background in clinical research and operational excellence.